{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:22:44Z","timestamp":1790878964662,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,28]]},"DOI":"10.7759\/cureus.21698","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T17:07:30Z","timestamp":1643389650000},"source":"Crossref","is-referenced-by-count":17,"title":["A Review of Cardiac Manifestations in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome With Focus on Endocarditis"],"prefix":"10.7759","author":[{"given":"Matthew G","family":"Tayem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Libman sacks endocarditis","author":"Ibrahim AM","year":"2021","unstructured":"Ibrahim AM, Siddique MS. Libman sacks endocarditis. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0491-z","article-title":"Autoimmune valvular carditis","volume":"15","author":"Breed ER","year":"2015","unstructured":"Breed ER, Binstadt BA. Autoimmune valvular carditis. Curr Allergy Asthma Rep. 2015, 15:491. 10.1007\/s11882-014-0491-z","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.59","article-title":"Infective endocarditis","volume":"2","author":"Holland TL","year":"2016","unstructured":"Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG Jr. Infective endocarditis. Nat Rev Dis Primers. 2016, 2:16059. 10.1038\/nrdp.2016.59","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2012.10.044","article-title":"Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis","volume":"95","author":"Katsouli A","year":"2013","unstructured":"Katsouli A, Massad MG. Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis. Ann Thorac Surg. 2013, 95:1467-74. 10.1016\/j.athoracsur.2012.10.044","journal-title":"Ann Thorac Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14740\/cr534e","article-title":"Lupus-negative Libman-Sacks endocarditis complicated by catastrophic antiphospholipid syndrome","volume":"8","author":"Murtaza G","year":"2017","unstructured":"Murtaza G, Iskandar J, Humphrey T, Adhikari S, Kuruvilla A. Lupus-negative Libman-Sacks endocarditis complicated by catastrophic antiphospholipid syndrome. Cardiol Res. 2017, 8:57-62. 10.14740\/cr534e","journal-title":"Cardiol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5626","article-title":"Infective endocarditis masquerading as rheumatoid arthritis","volume":"11","author":"Peechakara B","year":"2019","unstructured":"Peechakara B, Kadam A, Mewada M, Nakrani A. Infective endocarditis masquerading as rheumatoid arthritis. Cureus. 2019, 11:e5626. 10.7759\/cureus.5626","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5455\/ijsm.endocarditis","article-title":"Endocarditis in systemic lupus erythematosus","volume":"4","author":"Harzallah A","year":"2018","unstructured":"Harzallah A, Kaaroud H, Hamida B, Abdallah B. Endocarditis in systemic lupus erythematosus. International Journal of Surgery and Medicine. 2018, 4:158-63. 10.5455\/ijsm.endocarditis","journal-title":"International Journal of Surgery and Medicine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11638","article-title":"Overview and comparison of infectious endocarditis and non-infectious endocarditis: a review of 814 autoptic cases","volume":"33","author":"Bussani R","year":"2019","unstructured":"Bussani R, DE-Giorgio F, Pesel G, et al.. Overview and comparison of infectious endocarditis and non-infectious endocarditis: a review of 814 autoptic cases. In Vivo. 2019, 33:1565-72. 10.21873\/invivo.11638","journal-title":"In Vivo"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/157340308784245775","article-title":"Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors","volume":"4","author":"Zeller CB","year":"2008","unstructured":"Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008, 4:116-22. 10.2174\/157340308784245775","journal-title":"Curr Cardiol Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1586\/eci.10.98","article-title":"Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention","volume":"7","author":"McMahon M","year":"2011","unstructured":"McMahon M, Hahn BH, Skaggs BJ. Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention. Expert Rev Clin Immunol. 2011, 7:227-41. 10.1586\/eci.10.98","journal-title":"Expert Rev Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.93.8.1579","article-title":"Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome","volume":"93","author":"Hojnik M","year":"1996","unstructured":"Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996, 93:1579-87. 10.1161\/01.cir.93.8.1579","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.2217\/ijr.09.73","article-title":"Management of cardiovascular complications in systemic lupus erythematosus","volume":"5","author":"Skamra C","year":"2010","unstructured":"Skamra C, Ramsey-Goldman R. Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumtol. 2010, 5:75-100.","journal-title":"Int J Clin Rheumtol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.01.003","article-title":"Cardiac manifestations in antiphospholipid syndrome","volume":"6","author":"Solt\u00e9sz P","year":"2007","unstructured":"Solt\u00e9sz P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007, 6:379-86. 10.1016\/j.autrev.2007.01.003","journal-title":"Autoimmun Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/096120339600500306","article-title":"Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves","volume":"5","author":"Ziporen L","year":"1996","unstructured":"Ziporen L, Goldberg I, Arad M, et al.. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus. 1996, 5:196-205. 10.1177\/096120339600500306","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.10.3.339","article-title":"Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome","volume":"10","author":"Mohammadi Kebar Y","year":"2019","unstructured":"Mohammadi Kebar Y, Avesta L, Habibzadeh A, Hemmati M. Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome. Caspian J Intern Med. 2019, 10:339-42. 10.22088\/cjim.10.3.339","journal-title":"Caspian J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20910855","article-title":"An update on the management of antiphospholipid syndrome","volume":"12","author":"Rodziewicz M","year":"2020","unstructured":"Rodziewicz M, D'Cruz DP. An update on the management of antiphospholipid syndrome. Ther Adv Musculoskelet Dis. 2020, 12:10.1177\/1759720X20910855","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X10365969","article-title":"Management of antiphospholipid syndrome","volume":"2","author":"Del Papa N","year":"2010","unstructured":"Del Papa N, Vaso N. Management of antiphospholipid syndrome. Ther Adv Musculoskelet Dis. 2010, 2:221-7. 10.1177\/1759720X10365969","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref18","article-title":"Infectious endocarditis","author":"Yallowitz AW","year":"2020","unstructured":"Yallowitz AW, Decker LC. Infectious endocarditis. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMclde2108866","article-title":"Oral versus intravenous antibiotics for endocarditis","volume":"385","author":"Chowdhury J","year":"2021","unstructured":"Chowdhury J, Patel R, Chambers H. Oral versus intravenous antibiotics for endocarditis. N Engl J Med. 2021, 385:1141-3. 10.1056\/NEJMclde2108866","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-020-00471-1","article-title":"Myocardial involvement in rheumatic disorders","volume":"17","author":"Markousis-Mavrogenis G","year":"2020","unstructured":"Markousis-Mavrogenis G, Pepe A, Gargani L, et al.. Myocardial involvement in rheumatic disorders. Curr Heart Fail Rep. 2020, 17:171-80. 10.1007\/s11897-020-00471-1","journal-title":"Curr Heart Fail Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217653","article-title":"Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-na\u00efve, early rheumatoid arthritis","volume":"79","author":"Plein S","year":"2020","unstructured":"Plein S, Erhayiem B, Fent G, et al.. Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-na\u00efve, early rheumatoid arthritis. Ann Rheum Dis. 2020, 79:1414-22. 10.1136\/annrheumdis-2020-217653","journal-title":"Ann Rheum Dis"},{"key":"ref22","article-title":"Focus on periodontal disease and development of endocarditis","volume":"32","author":"Carinci F","year":"2018","unstructured":"Carinci F, Martinelli M, Contaldo M, et al.. Focus on periodontal disease and development of endocarditis. J Biol Regul Homeost Agents. 2018, 32:143-7.","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref23","article-title":"Cardiovascular involvement in autoimmune diseases","author":"Amaya-Amaya J","year":"2013","unstructured":"Amaya-Amaya J, Sarmiento-Monroy JC, Rojas-Villarraga A, et al.. Cardiovascular involvement in autoimmune diseases. Autoimmunity: from bench to bedside. Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al. (ed): El Rosario University Press, Bogota (Colombia); 2013. 18-38."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.4.547","article-title":"Systemic diseases caused by oral infection","volume":"13","author":"Li X","year":"2000","unstructured":"Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000, 13:547-58. 10.1128\/CMR.13.4.547","journal-title":"Clin Microbiol Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/596824","article-title":"Role of autoimmune responses in periodontal disease","volume":"2014","author":"Nair S","year":"2014","unstructured":"Nair S, Faizuddin M, Dharmapalan J. Role of autoimmune responses in periodontal disease. Autoimmune Dis. 2014, 2014:596824. 10.1155\/2014\/596824","journal-title":"Autoimmune Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2006.050308","article-title":"Anti-neutrophil cytoplasmic autoantibodies: a renewed paradigm in periodontal disease pathogenesis?","volume":"77","author":"Sharma CG","year":"2006","unstructured":"Sharma CG, Pradeep AR. Anti-neutrophil cytoplasmic autoantibodies: a renewed paradigm in periodontal disease pathogenesis?. J Periodontol. 2006, 77:1304-13. 10.1902\/jop.2006.050308","journal-title":"J Periodontol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14855","article-title":"Hyperuricemia and cardiovascular risk","volume":"13","author":"Shahin L","year":"2021","unstructured":"Shahin L, Patel KM, Heydari MK, Kesselman MM. Hyperuricemia and cardiovascular risk. Cureus. 2021, 13:e14855. 10.7759\/cureus.14855","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79804-a-review-of-cardiac-manifestations-in-patients-with-systemic-lupus-erythematosus-and-antiphospholipid-syndrome-with-focus-on-endocarditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:07Z","timestamp":1707507427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79804-a-review-of-cardiac-manifestations-in-patients-with-systemic-lupus-erythematosus-and-antiphospholipid-syndrome-with-focus-on-endocarditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.21698","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,28]]}}}